tiprankstipranks
H&R GmbH & Co. KGaA (DE:2HRA)
XETRA:2HRA
Want to see DE:2HRA full AI Analyst Report?

H&R GmbH & Co. KGaA (2HRA) AI Stock Analysis

5 Followers

Top Page

DE:2HRA

H&R GmbH & Co. KGaA

(XETRA:2HRA)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
€4.50
▲(3.21% Upside)
Action:Reiterated
Date:05/21/26
The score is held back primarily by weaker financial performance (declining revenue, compressed margins, and net losses), partially offset by strong recent operating and free cash flow. Technical indicators are broadly neutral, while valuation (P/E 10.5 and ~2.19% yield) provides moderate support.
Positive Factors
Cash Generation
Sustained operating cash flow (€126M TTM) and substantial free cash flow (€68.9M) create durable liquidity to fund capex, pay down debt, and support working capital. This cash strength cushions the business against cyclical earnings swings and enables strategic reinvestment.
Negative Factors
Revenue & Margin Pressure
Falling revenue and materially compressed gross margins weaken intrinsic earnings power. Lower margins reduce the buffer against feedstock and energy cost swings, limit room for reinvestment, and make profitability highly sensitive to product mix and cyclical demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash Generation
Sustained operating cash flow (€126M TTM) and substantial free cash flow (€68.9M) create durable liquidity to fund capex, pay down debt, and support working capital. This cash strength cushions the business against cyclical earnings swings and enables strategic reinvestment.
Read all positive factors

H&R GmbH & Co. KGaA (2HRA) vs. iShares MSCI Germany ETF (EWG)

H&R GmbH & Co. KGaA Business Overview & Revenue Model

Company Description
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment ma...
How the Company Makes Money
H&R makes money primarily by converting hydrocarbon feedstocks into higher-margin specialty and industrial products and selling them to business customers. Key revenue streams include: (1) Specialty chemicals: sales of chemical specialties derived...

H&R GmbH & Co. KGaA Financial Statement Overview

Summary
Mixed fundamentals: the income statement is weak (revenue down TTM, margins compressed, and a return to net losses), but cash flow is a clear strength with strong operating cash flow and positive free cash flow. The balance sheet looks manageable on leverage, though negative ROE highlights current profitability pressure.
Income Statement
34
Negative
Balance Sheet
56
Neutral
Cash Flow
63
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Mar 2023Dec 2021
Income Statement
Total Revenue1.20B1.24B1.34B1.35B1.58B1.19B
Gross Profit78.75M120.37M121.06M115.78M155.57M143.55M
EBITDA68.76M69.19M91.69M88.33M123.76M131.35M
Net Income-36.79M-38.80M10.62M10.56M42.71M50.18M
Balance Sheet
Total Assets943.44M950.42M1.01B903.24M962.07M874.38M
Cash, Cash Equivalents and Short-Term Investments75.41M70.96M64.01M69.44M55.89M48.92M
Total Debt136.06M183.09M194.60M202.61M244.24M196.28M
Total Liabilities515.48M534.34M546.26M445.62M490.91M465.90M
Stockholders Equity384.90M375.64M426.86M413.02M423.64M362.60M
Cash Flow
Free Cash Flow68.94M37.53M15.23M61.42M-32.04M-11.59M
Operating Cash Flow126.14M93.14M70.24M119.07M37.98M37.42M
Investing Cash Flow-60.05M-57.73M-54.45M-56.26M-72.46M-48.56M
Financing Cash Flow-48.61M-23.57M-25.80M-46.94M41.51M2.48M

H&R GmbH & Co. KGaA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.36
Price Trends
50DMA
4.39
Positive
100DMA
4.37
Positive
200DMA
4.60
Positive
Market Momentum
MACD
0.08
Positive
RSI
56.23
Neutral
STOCH
69.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:2HRA, the sentiment is Positive. The current price of 4.36 is below the 20-day moving average (MA) of 4.66, below the 50-day MA of 4.39, and below the 200-day MA of 4.60, indicating a bullish trend. The MACD of 0.08 indicates Positive momentum. The RSI at 56.23 is Neutral, neither overbought nor oversold. The STOCH value of 69.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:2HRA.

H&R GmbH & Co. KGaA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
€159.04M12.988.29%1.82%-41.38%-28.83%
62
Neutral
€45.36B25.685.24%5.16%-11.46%137.39%
59
Neutral
€656.56M-9.77-16.03%-19.00%32.12%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
€176.43M-5.02-9.29%2.27%-11.18%-433.15%
55
Neutral
€150.67M13.304.00%0.69%-3.31%134.05%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:2HRA
H&R GmbH & Co. KGaA
4.74
-0.26
-5.20%
DE:AAG
Aumann AG
13.85
1.28
10.14%
DE:BAS
BASF SE
50.82
10.48
25.98%
DE:GSC1
GESCO AG
13.90
-3.90
-21.90%
DE:SGL
SGL Carbon
5.37
1.75
48.34%
DE:OEL
ADM Hamburg Aktiengesellschaft
248.00
35.00
16.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 21, 2026